These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16972422)

  • 1. Patient information. The importance of homocysteine.
    Adv Nurse Pract; 2006 May; 14(5):31. PubMed ID: 16972422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment.
    Chamberlain KL
    J Am Acad Nurse Pract; 2005 Mar; 17(3):90-5. PubMed ID: 15748221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
    Gao L; Tang CS
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homocysteine paradox.
    Rodionov RN; Lentz SR
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1031-3. PubMed ID: 18495971
    [No Abstract]   [Full Text] [Related]  

  • 8. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia.
    Smulders YM
    Neth J Med; 2000 Oct; 57(4):172-3. PubMed ID: 11006495
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Homocysteine and hyperhomocysteinemia].
    Laskowska-Klita T
    Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin vs. a possible risk factor. Folate may offer protection--but don't let your guard down.
    Heart Advis; 2004 Jan; 7(1):6. PubMed ID: 15106563
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine: the latest risk factor for heart disease.
    Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
    Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
    Cheng X
    Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study.
    Akoglu B; Schrott M; Bolouri H; Jaffari A; Kutschera E; Caspary WF; Faust D
    Eur J Clin Nutr; 2008 Jun; 62(6):796-801. PubMed ID: 17522618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.